新型基于蛋白质的预后特征与卵巢癌的免疫治疗效率有关
Shuo-Fu Chen1, Liang-Yun Wang2, Yi-Sian Lin3
1Department of Heavy Particles & Radiation Oncology, Taipei Veterans General Hospital, Taipei, 112, Taiwan.
Journal of ovarian research
|September 28, 2024
概括
一种新的蛋白质特征可以准确预测卵巢癌的预后和免疫治疗反应. 该工具有助于识别那些可能从个性化癌症治疗中受益最多的患者.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 生物标志物发现发现
背景情况:
- 卵巢癌 (OC) 是异质的,需要个性化医疗方法,特别是免疫治疗.
- 确定可靠的生物标志物用于OC预后和预测免疫治疗反应仍然是一个重大的临床挑战.
- 多omics分析提供了一个有前途的策略,以了解OC中的瘤免疫相互作用.
研究的目的:
- 开发一种基于蛋白质的签名,用于使用蛋白质和转录基因数据预测卵巢癌的预后.
- 评估该签名能够预测免疫疗法反应的能力,并根据免疫微环境特征对患者进行分层.
主要方法:
- 利用逆相蛋白阵列 (RPPA) 和来自癌症基因组图谱 (TCGA) 卵巢癌队列的RNA测序数据.
- 采用与免疫相关的基因组聚类,随后进行LASSO和Cox回归以确定五种蛋白质的预后特征.
- 计算了患者的风险分数,并将签名的预后性能与传统的临床病理因素进行了比较.
主要成果:
- 一个经过验证的五种蛋白质签名在预测OC预后方面表现优于传统因素 (年龄,学年级,阶段,MSI,HRD).
- 高风险患者的整体存活率显著降低 (p < 0.001) 并且具有独特的免疫格局.
- 该签名在高风险组中发现了较高的CD8T细胞透率和潜在的免疫疗法响应者,与TGF-β通路协同激活有关.
结论:
- 蛋白质签名有效地帮助卵巢癌的预后,并提供了对瘤免疫微观环境的见解.
- 了解免疫抑制瘤微环境对于开发更有效的卵巢癌免疫疗法至关重要.
相关概念视频
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


